Harvard Apparatus Regenerative Technology HRGN
OTC HRGN
$2.19 -0.01 (-0.45%)
At close: Oct 2, 2026 · 4:00 PM EDT

Harvard Apparatus Regenerative Technology (HRGN) Research & Development (2012 - 2026)

Updated

Harvard Apparatus Regenerative Technology (HRGN) reported Research & Development of $948,000 for Q2 2026, up 36.0% from $697,000 a year earlier and up 68.4% from the prior quarter.

Analysis

Harvard Apparatus Regenerative Technology (HRGN) Research & Development (2012 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Harvard Apparatus Regenerative Technology's Research & Development came in at $2.87 million, up 34.8% year-over-year; for FY2025, it came in at $2.65 million, up 14.8% from FY2024.

  • Research & Development has a five-year compound annual growth rate of 5.1% (FY2020 to FY2025).
  • By year, Research & Development came in at $2.31 million in FY2024 (-24.6%), $3.06 million in FY2023 (+75.8%), $1.74 million in FY2022 (+9.4%) and $1.59 million in FY2021 (-23.1%).
  • The Q2 2026 figure ranks as the highest quarterly Research & Development since Q2 2023.
  • Year over year, Research & Development gained in five of the last eight quarters, with growth averaging 24.0%.
  • The high point for year-over-year Research & Development in five years was Q2 2023 (growth of 380.4%); the low point was Q2 2024 (a decline of 59.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $563,000 (Q1 2026), $700,000 (Q4 2025) and $655,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.82 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 3.65 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 2.34 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 9.74 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -2.85 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -4.05 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.87 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.76 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.81 Bn
10 Harvard Apparatus Regenerative Technology 38.50 Mn 35.01 Mn 23,000.00 948,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 948,000.00
Mar 31, 2026 563,000.00
Dec 31, 2025 700,000.00
Sep 30, 2025 655,000.00
Jun 30, 2025 697,000.00
Mar 31, 2025 601,000.00
Dec 31, 2024 271,000.00
Sep 30, 2024 557,000.00
Jun 30, 2024 642,000.00
Mar 31, 2024 840,000.00
Dec 31, 2023 648,000.00
Sep 30, 2023 339,000.00
Jun 30, 2023 1.57 Mn
Mar 31, 2023 509,000.00
Dec 31, 2022 744,000.00
Sep 30, 2022 369,000.00
Jun 30, 2022 326,000.00
Mar 31, 2022 303,000.00
Dec 31, 2021 569,000.00
Sep 30, 2021 250,000.00
API Access

Harvard Apparatus Regenerative Technology Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=HRGN&period=max&api_key=YOUR_API_KEY